Results 1 to 10 of about 7,787,676 (175)

Trends in sociodemographic factors associated with human papillomavirus vaccine hesitancy in the United States: 2010-2022. [PDF]

open access: yesCancer
Abstract Background Previous studies suggest that rates of human papillomavirus (HPV) vaccine hesitancy vary by adolescent and parent sociodemographic characteristics. This study assessed trends in the characteristics of parents who did not intend to have their child vaccinated for HPV in the United States.
Abouelella DK   +5 more
europepmc   +2 more sources

Human papillomavirus vaccine uptake and associated factors among schoolgirls in Sululta and Chancho towns, Central Ethiopia: a cross-sectional study [PDF]

open access: yesBMC Infectious Diseases
Background Cervical cancer is the second leading cause of cancer incidence and mortality among women in Ethiopia. The introduction of the human papillomavirus (HPV) vaccine is expected to substantially reduce the burden of the disease.
Habtamu Mekonnen Kessessa   +2 more
doaj   +2 more sources

An exploratory study of undergraduate healthcare student perspectives regarding human papillomavirus and vaccine intent in India

open access: yesWomen's Health, 2021
Objective: Safe and effective human papillomavirus vaccines are available against cervical cancer and other human papillomavirus–associated diseases. Vaccine uptake is low in India given lack of universal vaccination programme.
Seemitha Shetty   +3 more
doaj   +1 more source

Perception about human papillomavirus vaccination among middle adolescent school girls in Addis Ababa, Ethiopia 2023: qualitative study

open access: yesBMC Women's Health, 2023
Background Human papillomavirus vaccine uptake among school girls in Ethiopia was still low and uptake was majorly related to perception regarding the vaccine.
Abel Wubu   +3 more
doaj   +1 more source

Human Papillomavirus Knowledge, Perception, and Willingness to Receive Vaccination Among Female University Students in Addis Ababa University, Ethiopia, 2022: A Cross-Sectional Study

open access: yesSAGE Open Nursing, 2023
Background Cervical cancer is considered a leading cause of morbidity and mortality among females worldwide. Human papillomavirus is a highly prevalent sexually transmitted infection associated with increased cancer risks.
Teferi Regasa MSc   +2 more
doaj   +1 more source

Human papillomavirus vaccine acceptance among adolescent girls in Ethiopia: a systematic review and meta-analysis

open access: yesBMC Public Health, 2023
Background Cervical cancer is the fourth most common cancer affecting females. Human papillomavirus vaccination of adolescent girls is the primary strategy for cervical cancer prevention but in Ethiopia, it lacks emphasis.
Amare Zewdie   +4 more
doaj   +1 more source

ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PERCEPTION OF HUMAN PAPILLOMA VIRUS VACCINATION AMONG PARENTS OF YOUNG GIRLS (AGED 8 – 12) IN MBARARA CITY. A CROSS-SECTIONAL STUDY.

open access: yesStudent's Journal of Health Research Africa, 2023
Introduction: To reduce the cervical cancer burden, many governments have emphasized the Human papillomavirus (HPV) vaccine as an important prevention strategy.
Bright Twikirize   +2 more
doaj   +1 more source

Safety of 4-valent human papillomavirus vaccine in males: a large observational post-marketing study

open access: yesHuman Vaccines & Immunotherapeutics, 2022
The 4-valent human papillomavirus (HPV) vaccine (4vHPV vaccine), Gardasil®, is indicated for the prevention of several HPV-related diseases. The objective was to assess the safety of 4vHPV vaccine administered to males as part of routine care.
Kandace L. Amend   +6 more
doaj   +1 more source

Caregivers’ Willingness to Vaccinate Their Children against Childhood Diseases and Human Papillomavirus: A Cross-Sectional Study on Vaccine Hesitancy in Malawi

open access: yesVaccines, 2021
Background: Vaccines are among the most effective and cost-efficient public health interventions for promoting child health. However, uptake is considerably affected by vaccine hesitancy.
Gbadebo Collins Adeyanju   +3 more
doaj   +1 more source

Human papillomavirus vaccine

open access: yesSouth African Family Practice, 2013
No abstract available.
Jacqui Souter
doaj   +1 more source

Home - About - Disclaimer - Privacy